2026 Q3 Portfolio Activity
In 2026 Q3, Nan Fung Group Holdings Ltd maintained a portfolio of 30 distinct positions. The most significant new addition was OBSIDIAN THERAPEUTICS INC, now representing 8.43% of the total fund value. They heavily accumulated shares in PROCORE TECHNOLOGIES INC, increasing the position by 66.7%. The fund also reduced its exposure to RECURSION PHARMACEUTICALS IN by 69.5%.
Position History
hover any row below to update
Loading…
Total Positions
30
Quarter
2026 Q3
Top Holding
LBRX (16.2%)
Top 10 Concentration
75.7%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-30 of 30
Nan Fung Group Holdings Ltd Full Holdings List — 2026 Q3
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
LBRX
LB PHARMACEUTIC...
|
Healthcare | 16.17% | 15.57% |
#1
1
Prev: #2
|
7.0 |
—
|
no change | no change |
P
S
|
630,657 | $24,204,616 |
$20.44
+97.2%
|
2025 Q3 | 13F Filing | 2026-09-30 | 2026-11-13 | ||
|
MPLT
MAPLIGHT THERAP...
|
Healthcare | 15.66% | 26.47% |
#2
1
Prev: #1
|
8.5 |
—
|
1,329,075 | 136.8% |
P
S
|
2,300,328 | $23,440,342 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
OBX
OBSIDIAN THERAP...
|
Healthcare | 8.43% | — |
#3
Prev: #—
|
7.9 |
—
|
918,765 | — |
NEW
|
918,765 | $12,614,643 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
CYBN
CYBIN INC
|
Unknown | 8.11% | 4.96% |
#4
Prev: #4
|
4.7 |
—
|
no change | no change |
P
S
|
987,222 | $12,132,958 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
EVMN
EVOMMUNE INC
|
Healthcare | 7.95% | 14.56% |
#5
2
Prev: #3
|
4.7 |
—
|
no change | no change |
P
S
|
1,441,032 | $11,902,924 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
NUVB
NUVATION BIO IN...
|
Healthcare | 4.97% | — |
#6
Prev: #—
|
5.5 |
—
|
1,327,224 | — |
NEW
|
1,327,224 | $7,432,454 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
INCY
INCYTE CORP
|
Healthcare | 4.36% | 4.63% |
#7
2
Prev: #5
|
2.7 |
—
|
no change | no change |
P
S
|
53,742 | $6,521,592 | 2021 Q4 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
ONC
BEONE MEDICINES...
|
Healthcare | 3.84% | 3.41% |
#8
1
Prev: #7
|
2.5 |
—
|
no change | no change |
P
S
|
15,722 | $5,753,309 | 2021 Q4 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
RYTM
RHYTHM PHARMACE...
|
Healthcare | 3.12% | 4.15% |
#9
3
Prev: #6
|
2.2 |
—
|
no change | no change |
P
S
|
49,120 | $4,676,961 | 2022 Q4 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
PCOR
PROCORE TECHNOL...
|
Technology | 3.07% | 1.65% |
#10
7
Prev: #17
|
4.2 |
—
|
35,533 | 66.7% |
P
S
|
88,832 | $4,594,391 | 2025 Q4 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
NAMS
NEWAMSTERDAM PH...
|
Healthcare | 2.68% | — |
#11
Prev: #—
|
4.6 |
—
|
164,986 | — |
NEW
|
164,986 | $4,012,460 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
RVMD
REVOLUTION MEDI...
|
Healthcare | 2.64% | 2.74% |
#12
2
Prev: #10
|
2.1 |
—
|
no change | no change |
P
S
|
19,253 | $3,951,871 | 2024 Q1 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
KYMR
KYMERA THERAPEU...
|
Healthcare | 2.31% | 2.69% |
#13
2
Prev: #11
|
1.9 |
—
|
no change | no change |
P
S
|
30,875 | $3,451,516 | 2021 Q4 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
ASND
ASCENDIS PHARMA...
|
Healthcare | 2.07% | 2.76% |
#14
5
Prev: #9
|
1.8 |
—
|
no change | no change |
P
S
|
13,600 | $3,098,488 | 2021 Q4 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
MDGL
MADRIGAL PHARMA...
|
Healthcare | 1.91% | 2.32% |
#15
3
Prev: #12
|
1.8 |
—
|
no change | no change |
P
S
|
5,672 | $2,858,461 | 2022 Q4 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
OCS
OCULIS HOLDING ...
|
Healthcare | 1.88% | 3.17% |
#16
8
Prev: #8
|
1.8 |
—
|
no change | no change |
P
S
|
300,565 | $2,807,277 | 2023 Q1 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
ARGX
ARGENX SE
|
Healthcare | 1.79% | 1.98% |
#17
2
Prev: #15
|
1.7 |
—
|
no change | no change |
P
S
|
2,800 | $2,684,948 | 2021 Q4 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
N/A
TCGX ACQUISITIO...
|
|
Unknown | 1.67% | — |
#18
Prev: #—
|
4.2 |
—
|
200,000 | — |
NEW
|
200,000 | $2,502,000 | — | 13F Filing | 2026-09-30 | 2026-11-13 | ||
|
CELC
CELCUITY INC
|
Healthcare | 1.50% | 2.25% |
#19
6
Prev: #13
|
1.6 |
—
|
no change | no change |
P
S
|
28,300 | $2,250,416 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
ACAD
ACADIA PHARMACE...
|
Healthcare | 1.39% | 1.98% |
#20
6
Prev: #14
|
1.6 |
—
|
no change | no change |
P
S
|
102,984 | $2,075,128 | 2021 Q4 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
BRVE
BRAVEHEART BIO ...
|
Healthcare | 1.10% | — |
#21
Prev: #—
|
3.9 |
—
|
81,376 | — |
NEW
|
81,376 | $1,643,795 | 2026 Q3 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
HRMY
HARMONY BIOSCIE...
|
Healthcare | 0.71% | 0.75% |
#22
4
Prev: #18
|
1.3 |
—
|
no change | no change |
P
S
|
27,049 | $1,061,944 | 2021 Q2 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
ETHA
ISHARES ETHEREU...
|
ETF | 0.68% | 0.46% |
#23
3
Prev: #20
|
1.3 |
—
|
no change | no change |
P
S
|
50,549 | $1,017,046 | 2025 Q3 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
IBIT
ISHARES BITCOIN...
|
Bond/Debt | 0.51% | 0.40% |
#24
3
Prev: #21
|
1.2 |
—
|
no change | no change |
P
S
|
15,968 | $755,925 | 2025 Q3 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
INSM
INSMED INC
|
Healthcare | 0.50% | 0.53% |
#25
6
Prev: #19
|
1.2 |
—
|
no change | no change |
P
S
|
6,580 | $751,041 | 2026 Q1 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
RXRX
RECURSION PHARM...
|
Healthcare | 0.50% | 1.66% |
#26
10
Prev: #16
|
0.2 |
—
|
-413,656 | -69.5% |
P
S
|
181,631 | $750,136 | 2024 Q4 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
RANI
RANI THERAPEUTI...
|
Healthcare | 0.26% | 0.29% |
#27
4
Prev: #23
|
1.1 |
—
|
no change | no change |
P
S
|
493,584 | $390,425 | 2021 Q3 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
TRDA
ENTRADA THERAPE...
|
Healthcare | 0.21% | 0.27% |
#28
4
Prev: #24
|
1.1 |
—
|
no change | no change |
P
S
|
49,082 | $311,671 | 2022 Q1 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
BOLT
BOLT BIOTHERAPE...
|
Healthcare | 0.01% | 0.01% |
#29
4
Prev: #25
|
1.0 |
—
|
no change | no change |
P
S
|
5,000 | $18,400 | 2021 Q2 | 13F Filing | 2026-09-30 | 2026-11-13 | |||
|
CHYM
CHIME FINL INC
|
Technology | 0.00% | 0.33% |
Sold All 😨
(Was: #22) |
0.0 |
—
|
-21,075 | -100.0% |
CLOSED
|
— | $— | 2026 Q2 | 13F Filing | 2026-09-30 | 2026-11-13 |
Showing 1-30 of 30 holdings